Section 1.1: Human Physiology & Pathophysiology Foundations

Human Physiology & Pathophysiology Foundations

The Saudi Pharmacist Licensure Examination (SPLE) extensively evaluates basic human physiology and pathophysiology foundations, as these concepts underpin clinical pharmacology and pharmacotherapy. A deep understanding of organ systems—specifically the cardiovascular, renal, respiratory, endocrine, and nervous systems—is crucial for making appropriate clinical decisions, predicting drug effects, and recognizing side-effect profiles.

---

1. Cardiovascular Physiology & Pathophysiology

The primary function of the cardiovascular system is to maintain tissue perfusion, which is determined by cardiac output (CO) and systemic vascular resistance (SVR).

$\text{Cardiac Output } (CO) = \text{Heart Rate } (HR) \times \text{Stroke Volume } (SV)$

Stroke volume is governed by three primary factors:

1. Preload: The degree of myocardial stretch at the end of diastole, primarily determined by venous return and left ventricular end-diating volume (LVEDV). The Frank-Starling law dictates that within physiological limits, an increase in preload leads to an increase in stroke volume and cardiac output.
2. Afterload: The resistance against which the ventricle must contract to eject blood, primarily determined by systemic vascular resistance (SVR) and arterial stiffness.
3. Contractility (Inotropy): The intrinsic force of myocardial contraction at any given preload, mediated by intracellular calcium concentration.

Blood Pressure Regulation & Hemodynamics

• Baroreceptor Reflex: Located in the carotid sinus and aortic arch, baroreceptors detect changes in arterial stretch. A decrease in blood pressure reduces baroreceptor firing, triggering a compensatory increase in sympathetic outflow and a decrease in parasympathetic tone, resulting in vasoconstriction and increased heart rate.
• Renin-Angiotensin-Aldosterone System (RAAS): Triggered by low renal perfusion pressure, sympathetic stimulation (beta-1 receptors), or low sodium delivery to the macula densa. Renin converts angiotensinogen to angiotensin I. Angiotensin-converting enzyme (ACE) converts angiotensin I to angiotensin II (Ang II).
• Angiotensin II Actions: Ang II is a potent vasoconstrictor, stimulates aldosterone release from the adrenal cortex (promoting sodium and water retention), and promotes cardiac remodeling and hypertrophy.

Pathophysiology of Heart Failure (HF)

Heart failure represents a state of decreased cardiac output where the heart cannot meet metabolic demands. This leads to compensatory activation of the sympathetic nervous system (SNS) and RAAS, which initially maintains perfusion but eventually promotes maladaptive cardiac remodeling, myocardial fibrosis, and fluid overload (manifesting as pulmonary congestion or peripheral edema).

---

2. Renal Physiology & Acid-Base Balance

The nephron is the functional unit of the kidney, responsible for filtration, reabsorption, secretion, and excretion of solutes and water.

Nephron Segments and Drug Targets

1. Proximal Convoluted Tubule (PCT): Reabsorbs approximately 65% of filtered water and sodium. It is the target of carbonic anhydrase inhibitors (e.g., acetazolamide) and SGLT2 inhibitors (e.g., empagliflozin).
2. Loop of Henle:
   • Descending Limb: Highly permeable to water but impermeable to solutes, concentrating the tubular fluid.
   • Thick Ascending Limb (TAL): Impermeable to water but actively reabsorbs sodium, potassium, and chloride via the NKCC2 cotransporter (Na+/K+/2Cl-). This transporter is the target of loop diuretics (e.g., furosemide).
3. Distal Convoluted Tubule (DCT): Reabsorbs sodium and chloride via the NCC cotransporter (Na+/Cl-), which is inhibited by thiazide diuretics (e.g., hydrochlorothiazide). Calcium reabsorption here is stimulated by parathyroid hormone (PTH).
4. Collecting Duct: Contains Principal cells (reabsorb sodium via ENaC channels and secrete potassium; regulated by aldosterone) and Intercalated cells (regulate acid-base balance). Aquaporin-2 water channels are inserted in response to antidiuretic hormone (ADH) via V2 receptors to concentrate urine.

Regulation of Glomerular Filtration Rate (GFR)

GFR is regulated by adjusting the resistance of the afferent and efferent arterioles:

• Afferent arteriole dilation (mediated by prostaglandins) increases blood flow and GFR. Nonsteroidal anti-inflammatory drugs (NSAIDs) block prostaglandins, causing afferent vasoconstriction, which can precipitate acute kidney injury (AKI).
• Efferent arteriole constriction (mediated by Angiotensin II) increases intraglomerular pressure and maintains GFR. ACE inhibitors and ARBs block Ang II, causing efferent vasodilation, which decreases intraglomerular pressure and reduces GFR (manifesting as a transient rise in serum creatinine).

Renal Segments and Key Diuretics

Acid-Base Homeostasis

The kidneys and lungs work together to maintain blood pH between 7.35 and 7.45.

• Respiratory Acidosis: Caused by hypoventilation (retaining CO2). Renal compensation involves increased secretion of H+ and increased reabsorption of HCO3-.
• Respiratory Alkalosis: Caused by hyperventilation (excessive loss of CO2). Renal compensation involves increased excretion of HCO3-.
• Metabolic Acidosis: Caused by accumulation of fixed acids (e.g., diabetic ketoacidosis, lactic acidosis) or loss of bicarbonate (e.g., severe diarrhea). Respiratory compensation involves hyperventilation (Kussmaul breathing) to blow off CO2.
• Metabolic Alkalosis: Caused by loss of acid (e.g., severe vomiting) or excess bicarbonate. Respiratory compensation involves hypoventilation to retain CO2.

Acid-Base Disorders Summary Table

---

3. Respiratory Physiology & Pathophysiology

The respiratory system facilitates gas exchange between the atmosphere and pulmonary blood flow.

Ventilation and Gas Transport

• Oxygen-Hemoglobin Dissociation Curve: Describes the affinity of hemoglobin for oxygen.
  • Right Shift (decreased oxygen affinity, promoting oxygen release to tissues): Caused by increased temperature, increased 2,3-bisphosphoglycerate (2,3-BPG), increased hydrogen ion concentration (low pH/acidosis), and increased pCO2 (Bohr effect).
  • Left Shift (increased oxygen affinity, holding onto oxygen): Caused by decreased temperature, decreased 2,3-BPG, high pH (alkalosis), decreased pCO2, and carbon monoxide poisoning.

Obstructive vs. Restrictive Lung Diseases

• Obstructive Lung Diseases (e.g., Asthma, COPD): Characterized by airflow limitation due to increased resistance (bronchoconstriction, inflammation, mucus plug). FEV1 (Forced Expiratory Volume in 1 second) and FVC (Forced Vital Capacity) are both reduced, but the FEV1/FVC ratio is decreased (< 0.70).
• Restrictive Lung Diseases (e.g., Pulmonary Fibrosis): Characterized by restricted lung expansion and reduced total lung capacity. Both FEV1 and FVC are reduced proportionally, so the FEV1/FVC ratio remains normal or elevated (> 0.80).

---

4. Endocrine & Nervous System Physiology

Endocrine Regulation

• Thyroid Gland: The hypothalamic-pituitary-thyroid axis regulates metabolism. Hypothalamic TRH stimulates pituitary TSH, which drives the synthesis of thyroxine (T4) and triiodothyronine (T3). In primary hypothyroidism, TSH is elevated while free T4 is low. In primary hyperthyroidism, TSH is suppressed while free T4/T3 is high.
• Adrenal Gland: The adrenal cortex produces corticosteroids: aldosterone (mineralocorticoid from zona glomerulosa), cortisol (glucocorticoid from zona fasciculata), and androgens (from zona reticularis).
• Pancreatic Islets: Beta cells produce insulin (anabolic hormone that promotes cellular glucose uptake via GLUT4 translocation in skeletal muscle and adipose tissue), while alpha cells produce glucagon (catabolic hormone that stimulates glycogenolysis and gluconeogenesis in the liver).
• Pathophysiology of Diabetes: Type 1 DM involves autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency and susceptibility to diabetic ketoacidosis (DKA). Type 2 DM involves progressive insulin resistance combined with secretory dysfunction, leading to hyperglycemia and hyperosmolar hyperglycemic state (HHS).

Autonomic Nervous System (ANS)

The ANS regulates involuntary bodily functions through sympathetic (adrenergic) and parasympathetic (cholinergic) divisions.

Autonomic Receptors and Physiological Actions Table

Nervous System Pathophysiology

• Action Potential: Initiated by membrane depolarization exceeding threshold, opening voltage-gated Na+ channels (influx of sodium). Repolarization is driven by the closure of Na+ channels and opening of voltage-gated K+ channels (efflux of potassium).
• Neurotransmitter Imbalances:
  • Parkinson's Disease: Loss of dopaminergic neurons in the substantia nigra, leading to an imbalance with cholinergic neurons (excess acetylcholine).
  • Alzheimer's Disease: Characterized by progressive loss of cholinergic neurons in the nucleus basalis of Meynert, leading to severe acetylcholine deficiency.
  • Epilepsy: Uncontrolled, synchronous neuronal firing, often due to an imbalance between excitatory neurotransmission (glutamate) and inhibitory neurotransmission (GABA). Many anticonvulsants act by enhancing GABA activity or blocking voltage-gated Na+ or Ca2+ channels.